We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+7.59%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$446M
AUM Growth
+$46.7M
Cap. Flow
+$17.4M
Cap. Flow %
3.9%
Top 10 Hldgs %
68.66%
Holding
87
New
1
Increased
31
Reduced
30
Closed
9

Sector Composition

Rank Sector Weight
1 Miscellaneous 94.69%
2 Technology 3.03%
3 Consumer Discretionary 0.83%
4 Communication Services 0.62%
5 Consumer Staples 0.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKC icon
76
McCormick & Company Non-Voting
MKC
$14.9B
$219K 0.05%
2,256
-296
-12% -$29K
TLTD icon
77
Northern Trust Morningstar Developed Markets ex-US Factor Tilt ETF
TLTD
$690M
$205K 0.05%
+3,667
New +$206K
EVFM
78
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$118K 0.03%
3,333
AAXJ icon
79
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.88B
-5,905
Closed -$408K
AMAT icon
80
Applied Materials
AMAT
$366B
-6,378
Closed -$386K
BA icon
81
Boeing
BA
$166B
-2,551
Closed -$468K
CSCO icon
82
Cisco
CSCO
$433B
-21,859
Closed -$1.02M
DXJ icon
83
WisdomTree Japan Hedged Equity Fund
DXJ
$7.34B
-8,533
Closed -$401K
EWJ icon
84
iShares MSCI Japan ETF
EWJ
$22.7B
-3,775
Closed -$207K
IEV icon
85
iShares Europe ETF
IEV
$1.69B
-33,127
Closed -$1.34M
LAB icon
86
Standard BioTools
LAB
$252M
-17,400
Closed -$70K
V icon
87
Visa
V
$712B
-1,433
Closed -$277K

Similar funds

Callan Capital's Q3 2020 Portfolio in Review

As of Q3 2020, Callan Capital held 87 positions worth $446M, up 12% from $399M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Callan Capital deployed $17.4M of net new capital in Q3 2020, opening 1 new position and adding to 31 existing holdings. Its largest new stake was Northern Trust Morningstar Developed Markets ex-US Factor Tilt ETF: 3,667 shares worth $205K.

By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, up from 94% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Invesco FTSE RAFI US 1000 ETF, an estimated $5.87M trimmed.

  • Callan Capital's largest Q3 2020 buy was Northern Trust Morningstar Developed Markets ex-US Factor Tilt ETF: 3,667 shares worth $205K.
  • Callan Capital added most to Goldman Sachs ActiveBeta US Large Cap Equity ETF in Q3 2020, an estimated $8.21M increase.
  • Callan Capital's biggest Q3 2020 reduction was Invesco FTSE RAFI US 1000 ETF, cutting an estimated $5.87M.
  • Callan Capital fully exited iShares Europe ETF in Q3 2020, selling an estimated $1.34M.
  • Callan Capital's ten largest holdings make up 69% of its $446M portfolio in Q3 2020.
  • Callan Capital opened 1 new position and closed 9 in Q3 2020.
  • Callan Capital's portfolio value rose 12% quarter-over-quarter to $446M.

Based on Callan Capital's 13F filing for Q3 2020, filed 23 Oct 2020.